RING CHRISTINE (General Counsel) sold 64.6% of their position (16.59K shares) of NURIX THERAPEUTICS, INC. on the open market
Open‑market sale worth $382.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/3/2026ACC: 0001817199-26-000028
Officer· General Counsel
Since Jul 2020
-16.59K
Net shares
Net seller
$382.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5.79K acquired · 22.38K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5.79K
Price / share
$8.72
Trade value
$50.46K
% of position
29.1%
8/3/2026
19.91K→25.70K
Common Stock
Direct
Shares
−16.59K
Price / share
$23.05
Trade value
$382.36K
% of position
64.6%
8/3/2026
25.70K→9.11K
Total
Net shares
−10.80K
Net value
-$331.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2026 | M · Option Exercise | +5.79K | $8.72 | $50.46K | 29.1% | 19.91K | 25.70K |
| Common Stock Direct | 8/3/2026 | S · Sale | −16.59K | $23.05 | $382.36K | 64.6% | 25.70K | 9.11K |
| Total | −10.80K | -$331.90K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
5.79K shares
Shares
−5.79K
Strike price
8.72
Held after
122.82K
Exercisable
—
8/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock5.79K shares | 8/3/2026 | M · Option Exercise | −5.79K | 8.72 | — | 122.82K |